Real-world Effectiveness of Single-Agent Tivozanib in Patients with Metastatic Clear Cell Renal Cell Carcinoma.

Nandakumar V, Jo Y, Gebrael G, Ozay ZI, Upadhyay L, Goel K, Sayegh N, Srivastava A, Ostrowski M, Hardy T, Lin E, Thomas VM, Maughan BL, Li H, Agarwal N, Swami U

Open source

DOI: 10.15586/jkc.v13i3.472
Published: 2026
Container: Journal of kidney cancer and VHL
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.15586/jkc.v13i3.472,
  title = {Real-world Effectiveness of Single-Agent Tivozanib in Patients with Metastatic Clear Cell Renal Cell Carcinoma.},
  author = {Nandakumar V and Jo Y and Gebrael G and Ozay ZI and Upadhyay L and Goel K and Sayegh N and Srivastava A and Ostrowski M and Hardy T and Lin E and Thomas VM and Maughan BL and Li H and Agarwal N and Swami U},
  year = {2026},
  journal = {Journal of kidney cancer and VHL},
  doi = {10.15586/jkc.v13i3.472},
  url = {https://doi.org/10.15586/jkc.v13i3.472}
}

RIS

TY  - JOUR
TI  - Real-world Effectiveness of Single-Agent Tivozanib in Patients with Metastatic Clear Cell Renal Cell Carcinoma.
AU  - Nandakumar V
AU  - Jo Y
AU  - Gebrael G
AU  - Ozay ZI
AU  - Upadhyay L
AU  - Goel K
AU  - Sayegh N
AU  - Srivastava A
AU  - Ostrowski M
AU  - Hardy T
AU  - Lin E
AU  - Thomas VM
AU  - Maughan BL
AU  - Li H
AU  - Agarwal N
AU  - Swami U
PY  - 2026
JO  - Journal of kidney cancer and VHL
DO  - 10.15586/jkc.v13i3.472
UR  - https://doi.org/10.15586/jkc.v13i3.472
ER  -

APA

V, N., Y, J., G, G., ZI, O., L, U., K, G., N, S., A, S., M, O., T, H., E, L., VM, T., BL, M., H, L., N, A., & U, S. (2026). Real-world Effectiveness of Single-Agent Tivozanib in Patients with Metastatic Clear Cell Renal Cell Carcinoma.. Journal of kidney cancer and VHL. https://doi.org/10.15586/jkc.v13i3.472

Source records

pubmed · retrieved 2026-09-26T08:49:26.875Z
europe-pmc · retrieved 2026-09-26T08:49:26.890Z